Large-scale testing (Phase 3)Study completedNCT02229383
What this trial is testing
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
Who this might be right for
Diabetes Mellitus
AstraZeneca 464